Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Bando

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Clinical Colorectal Cancer|November 15, 2021
Novel Immunological Approaches in the Treatment of Locally Advanced Rectal CancerHideaki Bando, Yuichiro Tsukada, Masaaki Ito, et al.
Future Oncology (London, England)|June 15, 2022
The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial dataSatoru Iwasa, Hideaki Bando, Yongzhe Piao, et al.
Cancer Science|August 25, 2018
Utility of the quasi-monomorphic variation range in unresectable metastatic colorectal cancer patientsHideaki Bando, Wataru Okamoto, Takafumi Fukui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 24, 2016
[Efficacy of Ipragliflozin in Patients with Steroid-Induced Hyperglycemia during Cancer Chemotherapy]Satoshi Horasawa, Keiichiro Osame, Kenji Kawasumi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancerTadaaki Yamada, Shinji Takeuchi, Kenji Kita, et al.
Journal of Medical Case Reports|November 26, 2020
Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case reportSachiyo Onishi, Masahiro Tajika, Hideaki Bando, et al.
Japanese Journal of Clinical Oncology|November 7, 2019
Clinical impact of renal impairment on the safety and efficacy of S-1 plus oxaliplatin in patients with advanced gastric cancer: a single institutional studyKen Demachi, Hideaki Bando, Hisanaga Nomura, et al.
Japanese Journal of Clinical Oncology|August 11, 2010
Feasibility and robustness of amplification refractory mutation system (ARMS)-based KRAS testing using clinically available formalin-fixed, paraffin-embedded samples of colorectal cancersNaomi Ogasawara, Hideaki Bando, Yasuyuki Kawamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 30, 2023
[Integration Process of Clinical Trial Data in ARCAD-Asia]Hideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 12, 2016
Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trialsHideaki Bando, Larry Rubinstein, Pamela Harris, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Clinical Colorectal Cancer|November 15, 2021
Novel Immunological Approaches in the Treatment of Locally Advanced Rectal CancerHideaki Bando, Yuichiro Tsukada, Masaaki Ito, et al.
Future Oncology (London, England)|June 15, 2022
The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial dataSatoru Iwasa, Hideaki Bando, Yongzhe Piao, et al.
Cancer Science|August 25, 2018
Utility of the quasi-monomorphic variation range in unresectable metastatic colorectal cancer patientsHideaki Bando, Wataru Okamoto, Takafumi Fukui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 24, 2016
[Efficacy of Ipragliflozin in Patients with Steroid-Induced Hyperglycemia during Cancer Chemotherapy]Satoshi Horasawa, Keiichiro Osame, Kenji Kawasumi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancerTadaaki Yamada, Shinji Takeuchi, Kenji Kita, et al.
Journal of Medical Case Reports|November 26, 2020
Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case reportSachiyo Onishi, Masahiro Tajika, Hideaki Bando, et al.
Japanese Journal of Clinical Oncology|November 7, 2019
Clinical impact of renal impairment on the safety and efficacy of S-1 plus oxaliplatin in patients with advanced gastric cancer: a single institutional studyKen Demachi, Hideaki Bando, Hisanaga Nomura, et al.
Japanese Journal of Clinical Oncology|August 11, 2010
Feasibility and robustness of amplification refractory mutation system (ARMS)-based KRAS testing using clinically available formalin-fixed, paraffin-embedded samples of colorectal cancersNaomi Ogasawara, Hideaki Bando, Yasuyuki Kawamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 30, 2023
[Integration Process of Clinical Trial Data in ARCAD-Asia]Hideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 12, 2016
Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trialsHideaki Bando, Larry Rubinstein, Pamela Harris, et al.
Pageof 19